Company / Cash & Equivalents
Alignment Healthcare, Inc. Cash & Equivalents History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$575.8M
FY2025
5-year range
$202.9M / $575.8M
FY2021-FY2025
Trend
+33.0%
vs FY2024
Sector context
#44 of 152
Health Care
What the data says
At $576M, Alignment Healthcare, Inc.'s cash & equivalents ranks #44 of 152 in the Health Care sector. Improved from $203M to $576M over the past 2 years.
Based on SEC 10-K filings.
$576M in FY2025 with a 5-year CAGR of +22.7%.
Improved from $203M to $576M over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +12.0%
- 5-Year CAGR
- +22.7%
- 10-Year CAGR
- -
Sector benchmark
#44 of 152 in Health CareTop 29% of 152This company $575.8M Sector average $1.2B
▼
-50.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +22.7%, indicating consistent growth.
- In FY2025, cash & equivalents increased 33.0% year-over-year.
- Ranks #44 out of 152 companies in the Health Care sector.
- Lowest cash & equivalents in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 3.29 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $575.8M | +33.0% |
| FY2024 | $432.9M | +113.3% |
| FY2023 | $202.9M | -50.5% |
| FY2022 | $409.5M | -12.2% |
| FY2021 | $466.6M | +125.1% |
| FY2020 | $207.3M | +139.7% |
| FY2019 | $86.5M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026